Avasimibe : Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles

Fostamatinib: Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond

Inavolisib: Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Ka inhibitors